SCHEMBL5519146

SCHEMBL5519146

O=COC1CCCC1C(=O)Nc1ccc(-c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.61
LMNA P02545 2/20 0.61
SMN1; SMN2 Q16637 3/20 0.53
HPGD P15428 3/20 0.53
MAPT P10636 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
NPC1 O15118 1/20 0.53
FNTA P49354 1/20 0.48
FNTB P49356 1/20 0.48
GAA P10253 1/20 0.48
DGAT1 O75907 3/20 0.46
PTPN1 P18031 3/20 0.44
KDM4E B2RXH2 2/20 0.43
HTT P42858 2/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
POLB P06746 1/20 0.43
CYP2C19 P33261 1/20 0.42
PTPN2 P17706 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5519141 0.79 RAB9A (0.94) RAB9ALMNASMN1; SMN2HPGDMAPT
SCHEMBL3917111 0.76 RAB9A (1.00) RAB9ALMNASMN1; SMN2HPGDMAPT
SCHEMBL12248066 0.75 HPGD (0.57) RAB9ASMN1; SMN2HPGDNPC1ALDH1A1
SCHEMBL367815 0.74 GRM4 (0.63) RAB9AMEN1KMT2AGAAHTT
SCHEMBL1849287 0.72 ADORA2A (0.49)
SCHEMBL5511055 0.72 DHODH (0.54) RAB9ASMN1; SMN2NPC1DGAT1
SCHEMBL5514729 0.72 DHODH (0.50) MEN1KMT2AALDH1A1CYP2C19
SCHEMBL11756611 0.71 MCL1 (0.44) RAB9AMEN1KMT2ANPC1DGAT1
SCHEMBL10337750 0.70 MAPT (0.78) RAB9ALMNASMN1; SMN2HPGDMAPT
SCHEMBL105931 0.70 MAPT (0.78) RAB9ALMNASMN1; SMN2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070224672-A1 Method of Identifying Inhibitors of DHODH LEBAN JOHANN 2007-09-27 US disclosed
US-7247736-B2 Method of identifying inhibitors of DHODH 4SC AG (DE) 2007-07-24 US disclosed
US-20070027193-A1 Method of identifying inhibitors of DHODH 4SC AG (DE) 2007-02-01 US disclosed
EP-1581478-A1 DHODH-INHIBITORS AND METHOD FOR THEIR IDENTIFICATION 4SC AG (DE) 2005-10-05 EP disclosed
WO-2004056747-A1 DHODH-INHIBITORS AND METHOD FOR THEIR IDENTIFICATION 4SC AG (DE) 2004-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027193-A1 Method of identifying inhibitors of DHODH DHODH, SQOR, NDUFA5 RAB9A 2708/4885LMNA 3183/4885SMN1; SMN2 4472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.